The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
White Papers
This paper explores nine different methods of replenishing a hospital storage area and compares and contrasts the steps nursing must progress thr
White Papers
The Purpose of this white paper is to prepare Supply Chain professionals to better understand how to support navigating some of the risks and oppor
Supply Chain Strategies & Solutions Article
Medical device manufacturers have been working hard to comply with the new Unique Device Identification (UDI) regulations from the FDA that are aim
Supply Chain Strategies & Solutions Article
Healthcare reform is driving unprecedented changes in the management, funding and delivery of care as hospitals develop and implement strategies to
Supply Chain Strategies & Solutions Article
The evolution of our healthcare system from a volume-based to a value-based model is driving provider organizations to adopt patient-centric, outco
Supply Chain Strategies & Solutions Article
HealthTrust recently created the Physician Advisors Program, which is narrowing the chasm between those who purchase products and those who use the